This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
FXR activated by bile acids repress apoC3 expression and thus lowers plasma triglycerides levels
FXR agonists could help hyper triglyceridemic patients
This page is a summary of: Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression, Gastroenterology, August 2003, Elsevier,
DOI: 10.1016/s0016-5085(03)00896-5.
You can read the full text:
The following have contributed to this page
Language Speech and Hearing Services in Schools
This article describes the iterative development of a promising online vocabulary program, DictionarySquared. It provides a theoretical model for how DictionarySquared improves vocabulary and repor...
Journal of Neurological Surgery Part B Skull Base
Diagnostic Audiology
The Spine Journal
To assess the safety of L5−S1 inclusion in OLIF, we retrospectively studied 87 patients who underwent lumbar fusion using the OLIF approach. Of these, the L5-S1 level was included in 19 patients an...
